These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1640660)

  • 1. Suppression by cyclosporin A of anti-GBM nephritis in rats.
    Nagamatsu T; Kojima N; Kondo N; Hattori T; Kojima R; Ito M; Suzuki Y
    Jpn J Pharmacol; 1992 Jan; 58(1):27-36. PubMed ID: 1640660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the antinephritic effects of plant components (6): antinephritic effects and mechanisms of phellodendrine (OB-5) on crescentic-type anti-GBM nephritis in rats (2).
    Hattori T; Furuta K; Hayashi K; Nagamatsu T; Ito M; Suzuki Y
    Jpn J Pharmacol; 1992 Nov; 60(3):187-95. PubMed ID: 1491511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinephritic effect of Y-19018, a thromboxane A synthetase inhibitor, on crescentic-type anti-GBM nephritis in rats.
    Suzuki Y; Tsukushi Y; Ito M; Nagamatsu T
    Jpn J Pharmacol; 1987 Oct; 45(2):177-85. PubMed ID: 3437587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A and anti-glomerular basement membrane antibody glomerulonephritis in rats.
    Wood A; Adu D; Birtwistle RJ; Brewer DB; Michael J
    Br J Exp Pathol; 1988 Apr; 69(2):189-95. PubMed ID: 3259890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of cyclosporin A on experimental nephritis in rats (2): Cyclosporin A suppresses the development of accelerated passive Heymann nephritis].
    Nagamatsu T; Kojima N; Suzuki Y
    Nihon Yakurigaku Zasshi; 1994 Jan; 103(1):19-26. PubMed ID: 7508879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of ED-1- and CD-8-positive cells to the development of crescentic-type anti-GBM nephritis in rats.
    Hattori T; Nagamatsu T; Ito M; Suzuki Y
    Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1228-39. PubMed ID: 7853754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of experimental crescentic-type anti-glomerular basement membrane (GBM) nephritis by FK506 (tacrolimus hydrate) in rats.
    Hayashi K; Nagamatsu T; Ito M; Suzuki Y
    Jpn J Pharmacol; 1996 Jan; 70(1):43-54. PubMed ID: 8822088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinephritic effect of OKY-046, a thromboxane A synthetase inhibitor (1). Effects on crescentic-type anti-GBM nephritis in rats.
    Nagamatsu T; Tsukushi Y; Ito M; Kondo N; Suzuki Y
    Jpn J Pharmacol; 1989 Apr; 49(4):501-9. PubMed ID: 2724689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cyclosporin A on antibody-induced experimental glomerulonephritis.
    Tipping PG; Holdsworth SR
    Nephron; 1985; 40(2):201-5. PubMed ID: 3889677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of anti-glomerular basement membrane nephritis in rats by ONO-1301, a non-prostanoid prostaglandin I2 mimetic compound with inhibitory activity against thromboxane A2 synthase.
    Hayashi K; Nagamatsu T; Oka T; Suzuki Y
    Jpn J Pharmacol; 1997 Jan; 73(1):73-82. PubMed ID: 9032136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological studies on experimental nephritic rats (11). Changes in pathohistological and biochemical parameters in anti-rat GBM rabbit serum-induced nephritis (author's transl)].
    Suzuki Y; Nagamatsu T; Kito T; Kohmura T; Ito M
    Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):407-17. PubMed ID: 7286845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butein ameliorates experimental anti-glomerular basement membrane (GBM) antibody-associated glomerulonephritis in rats (1).
    Hayashi K; Nagamatsu T; Honda S; Suzuki Y
    Jpn J Pharmacol; 1996 Jan; 70(1):55-64. PubMed ID: 8822089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acteoside, a component of Stachys sieboldii MIQ, may be a promising antinephritic agent (2): Effect of acteoside on leukocyte accumulation in the glomeruli of nephritic rats.
    Hayashi K; Nagamatsu T; Ito M; Hattori T; Suzuki Y
    Jpn J Pharmacol; 1994 Sep; 66(1):47-52. PubMed ID: 7532244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crescentic type nephritis induced by anti-glomerular basement membrane (GBM) serum in rats.
    Ito M; Yamada H; Okamoto K; Suzuki Y
    Jpn J Pharmacol; 1983 Dec; 33(6):1145-54. PubMed ID: 6668763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cyclosporin A on the interstitial mononuclear cell infiltration and the induction of Heymann's nephritis.
    Grönhagen-Riska C; von Willebrand E; Tikkanen T; Honkanen E; Miettinen A; Holthöfer H; Törnroth T
    Clin Exp Immunol; 1990 Feb; 79(2):266-72. PubMed ID: 2311304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on antinephritic effects of plant components (3): Effect of pachyman, a main component of Poria cocos Wolf on original-type anti-GBM nephritis in rats and its mechanisms.
    Hattori T; Hayashi K; Nagao T; Furuta K; Ito M; Suzuki Y
    Jpn J Pharmacol; 1992 May; 59(1):89-96. PubMed ID: 1507662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on antinephritic effect of mizoribine (p-INN, Bredinin), a new immunosuppressive agent, and azathioprine. (2) Effect on crescentic-type anti-GBM nephritis in rats.
    Okamoto K; Ito M; Suzuki Y
    Jpn J Pharmacol; 1984 Jan; 34(1):33-41. PubMed ID: 6716716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetoside, a component of Stachys sieboldii MIQ, may be a promising antinephritic agent: effect of acteoside on crescentic-type anti-GBM nephritis in rats.
    Hayashi K; Nagamatsu T; Ito M; Hattori T; Suzuki Y
    Jpn J Pharmacol; 1994 Jun; 65(2):143-51. PubMed ID: 7526020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of anti-glomerular basement membrane antibody-induced glomerulonephritis in inbred rats with isologous antibodies from the urine of nephritic rats.
    Sado Y; Naito I; Okigaki T
    J Pathol; 1989 Aug; 158(4):325-32. PubMed ID: 2769491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked antinephritic action and less adverse effects of methylprednisolone suleptanate by intermittent administration in rats.
    Taniguchi H; Nagamatsu T; Kojima R; Ito M; Suzuki Y
    Jpn J Pharmacol; 1994 Feb; 64(2):79-88. PubMed ID: 8028233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.